| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/17/2009 | US20090233917 Stroke recovery |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/17/2009 | US20090233898 Pharmaceutical Compositions Comprising Simvastatin and Ezetimibe |
| 09/17/2009 | US20090233880 Equol production accelerating composition |
| 09/17/2009 | US20090233845 Methods and compositions for non-covalently enhanced receptor binding |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233363 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/17/2009 | US20090232913 Composition for the Control of Cholesterol Levels |
| 09/17/2009 | US20090232866 Oligopeptides as coating material for medical products |
| 09/17/2009 | US20090232865 End-Capped Poly(Ester Amide) Copolymers |
| 09/17/2009 | US20090232850 Therapeutic treatments using botulinum neurotoxin |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | CA2750859A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 09/17/2009 | CA2718056A1 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 09/17/2009 | CA2717351A1 A combination drug for treating vascular disorder |
| 09/17/2009 | CA2717322A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | CA2716101A1 Phytol as a cholesterol lowering agent |
| 09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | CA2710797A1 Imidazo[1,2-.alpha.]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2099799A1 Spiro-piperidine derivatives |
| 09/16/2009 | EP2099788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
| 09/16/2009 | EP2099786A1 Process for preparing a crystalline form of candesartan cilexetil |
| 09/16/2009 | EP2099781A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
| 09/16/2009 | EP2099754A1 Ion channel modulators |
| 09/16/2009 | EP2099753A2 Heteroarylacrylamides and their use as pharmaceuticals |
| 09/16/2009 | EP2099453A2 Combination therapy of substituted oxazolidinones |
| 09/16/2009 | EP2099441A1 Metal delivery agents and therapeutic uses of the same |
| 09/16/2009 | EP2099439A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/16/2009 | EP1661909B1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/16/2009 | EP1578737B1 Substituted heterocyclic compounds |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | CN101532027A Hypoxia inducible eukaryotic gene expression vector and application thereof |
| 09/16/2009 | CN101531718A Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531652A Novel method for extracting anthocyanin in bilberry by double water phases |
| 09/16/2009 | CN101531643A Synthesis method for improved cinepazide maleate |
| 09/16/2009 | CN101531638A Compound used as a regulator of estrogen-related receptor and applications thereof |
| 09/16/2009 | CN101531629A Method for preparing levamlodipine from racemic amlodipine maleate |
| 09/16/2009 | CN101531601A Method for separating and analyzing dopexamine hydrochloride by using HPLC method |
| 09/16/2009 | CN101530620A Triphosadenine intercalated houghite membrane and preparation method thereof |
| 09/16/2009 | CN101530609A Nanometer Shuxuetong injection preparation and preparation method thereof |
| 09/16/2009 | CN101530601A Astragalus edge tablets and its quality control method |
| 09/16/2009 | CN101530590A Pearl capsule with twenty-five components, preparation method and quality detection method thereof |
| 09/16/2009 | CN101530587A Medicament for treating abasia and rheumatism |
| 09/16/2009 | CN101530569A Chinese traditional medicine for curing hypertensive |
| 09/16/2009 | CN101530556A Chinese traditional medicine preparation used for curing angina |
| 09/16/2009 | CN101530534A Oral pharmaceutical preparation of dioscorea panthaica total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530532A Oral pharmaceutical preparation of yam total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530520A Deflocculat suppository powder |
| 09/16/2009 | CN101530518A Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof |
| 09/16/2009 | CN101530500A Therapeutic effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530499A Prevention effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530498A Improvement effect of blood-nourishing and brain-refreshing granules on cerebral microcirculatory disturbance |
| 09/16/2009 | CN101530482A Application of ranunculin in preparing medicines for curing cardiovascular diseases |
| 09/16/2009 | CN101530480A Quality inspection method for quick-acting cardiac pain spray |
| 09/16/2009 | CN101530478A Chinese medicinal composition with efficacies of preventing myocardial infarct and cerebral infarct, dissolving and eliminating thrombus, activating blood and dissolving stasis, and resisting ageing |
| 09/16/2009 | CN101530467A Protection effect of compound Danshen dropping pill on cordis microcirculatory disturbance and myocardial damage |
| 09/16/2009 | CN101530459A Application of licorice flavones preparation |
| 09/16/2009 | CN101530454A Applications of pterocarpus indicus extract on inhibition of blood platelet aggregation |
| 09/16/2009 | CN101530453A Method for preparing pterocarpus santalinus water extract used as direct vasodilation agent and applications of method |
| 09/16/2009 | CN101530452A Method for preparing pterocarpus indicus ethanol extract used for direct vasodilation agent and applications of method |
| 09/16/2009 | CN101530451A Method for preparing pterocarpus indicus water extract used for endothelium-dependent vasodilation agent and applications of method |
| 09/16/2009 | CN101530450A Method for preparing pterocarpus indicus ethanol extract used for endothelium-dependent vasodilation agent and applications of method |
| 09/16/2009 | CN101530446A General ixeris flavone extract slow-release preparation and application |
| 09/16/2009 | CN101530445A Dry extract of chrysanthemum |
| 09/16/2009 | CN101530444A Soft capsules of volatile oil of chrysanthemum |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN101530424A Preparation of palaeo-oceanographical organism medical stone with muscle-penetrating applying treatment for health preservation, rehabilitation and health care |
| 09/16/2009 | CN101530414A Applications of compound ketanserin |
| 09/16/2009 | CN101530409A Thrombi-resistant application of salvianolic acid B |
| 09/16/2009 | CN101530396A Method for preparing an amlodipine microsphere |
| 09/16/2009 | CN101530391A Creatine phosphate sodium lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN101530388A Formulation of mildronate injection and preparation method |
| 09/16/2009 | CN100540570C Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540560C Compounds that interact with kinases |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/16/2009 | CN100540523C Novel L-2-(alpha-hydroxy pentyl)benzoate and its preparation method and use |
| 09/16/2009 | CN100540058C Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/16/2009 | CN100540004C Nasal pharmaceutical composition of piribedil |
| 09/15/2009 | US7589126 Useful as potent and selective activated blood coagulation factor X inhibitors, anticoagulants; for example, ethyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl)benzenesulfonyl-amino]ethyl]-2'-methanesulfonylbiphenyl-3-yloxy]acetate; brain and cardiovascular disorders |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/15/2009 | US7589095 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |